Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Annals of Neurology

• Publication date

  1994-12-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/ana.410360613PMID 7998775
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Involvement of Free Radicals in Excitotoxicity In Vivo

  1995cited by this paper
• Malonate produces striatal lesions by indirect NMDA receptor activation.

  1994cited by this paper
• Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity.

  1994cited by this paper
• Invalidity of the Rao map function for three loci.

  1994cited by this paper
• Coenzyme Q10 with multiple vitamins is generally ineffective in treatment of mitochondrial disease

  1993cited by this paper
• Treatment of complex I deficiency with riboflavin.

  1993cited by this paper
• Inhibition of Succinate Dehydrogenase by Malonic Acid Produces an “Excitotoxic” Lesion in Rat Striatum

  1993cited by this paper
• Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid

  1993cited by this paper
• Age‐Dependent Striatal Excitotoxic Lesions Produced by the Endogenous Mitochondrial Inhibitor Malonate

  1993cited by this paper
• Age‐Dependent Vulnerability of the Striatum to the Mitochondrial Toxin 3‐Nitropropionic Acid

  1993cited by this paper
• Ubiquinone Protects Cultured Neurons against Spontaneous and Excitotoxin-Induced Degeneration

  1992cited by this paper
• Tissue concentrations of coenzyme Q10 in the rat following its oral and intraperitoneal administration.

  1992cited by this paper
• MELAS syndrome with mitochondrial tRNA Leu[UUR] mutation

  1992cited by this paper
• Alternative excitotoxic hypotheses

  1992cited by this paper
• 1‐Methyl‐4‐Phenylpyridinium Produces Excitotoxic Lesions in Rat Striatum as a Result of Impairment of Oxidative Metabolism

  1992cited by this paper
• Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?

  1992cited by this paper
• Marked reduction in CSF lactate and pyruvate levels after CoQ therapy in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke‐like episodes (MELAS)

  1991cited by this paper
• Aminooxyacetic Acid Results in Excitotoxin Lesions by a Novel Indirect Mechanism

  1991cited by this paper
• Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: relationship with phencyclidine-like behavioral effects.

  1990cited by this paper
• Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations.

  1990cited by this paper
• Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites

  1989cited by this paper
• Long‐term coenzyme Q10 therapy for a mitochondrial encephalomyopathy with cytochrome c oxidase deficiency

  1989cited by this paper
• Subject Index, Vol. 39, 1989

  1989cited by this paper
• Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy.

  1989cited by this paper
• Mitochondrial encephalomyopathy (MELAS): pathological study and successful therapy with coenzyme Q10 and idebenone.

  1989cited by this paper
• Clinical and biochemical correlations in mitochondrial myopathies treated with coenzyme Q10

  1988cited by this paper
• Effect of High Doses of Dietary Vitamin E on the Concentrations of Vitamin E in Several Brain Regions, Plasma, Liver, and Adipose Tissue of Rats

  1988cited by this paper
• Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced.

  1988cited by this paper
• Therapy of mitochondrial disorders

  1987cited by this paper
• Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase.

  1986cited by this paper
• Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5

  1986cited by this paper
• Lateral diffusion of ubiquinone during electron transfer in phospholipid- and ubiquinone-enriched mitochondrial membranes.

  1982cited by this paper
• A protective effect of coenzyme Q10 on ischemia and reperfusion of the isolated perfused rat heart.

  1981cited by this paper
• The enzymatic measurement of adenine nucleotides and P-creatine in picomole amounts.

  1981cited by this paper
• Fluorometric assay of proteins in the nanogram range.

  1973cited by this paper

• In-vitro and in-vivo studies of two-drug cocktail therapy targeting chemobrain via the Nrf2/NF-κB signaling pathway

  2024cites this paper
• Therapeutic application of nicotinamide: As a potential target for inhibiting fibrotic scar formation following spinal cord injury

  2024cites this paper
• Nicotinamide: Bright Potential in Glaucoma Management

  2024cites this paper
• Revolutionizing our understanding of Parkinson’s disease: Dr. Heinz Reichmann’s pioneering research and future research direction

  2024cites this paper
• Optic Nerve Neuroprotection in Glaucoma: A Narrative Review

  2024cites this paper
• Co-administration of chloroquine and coenzyme Q10 improved treatment outcome during experimental cerebral malaria

  2022cites this paper
• Coenzyme Q10 a mitochondrial restorer for various brain disorders

  2021cites this paper
• Potential Therapeutic Use of Coenzyme Q10 in Diabetes Mellitus and Its Complications: an Algorithm of Scoping Clinical Review

  2021cites this paper
• Oxidative Stress and Cognitive Decline: The Neuroprotective Role of Natural Antioxidants

  2021cites this paper
• Neuroprotective efficacy of nano‐CoQ against propionic acid toxicity in rats: Role of BDNF and CREB protein expressions

  2020cites this paper
• Cellular Consequences of Coenzyme Q10 Deficiency in Neurodegeneration of the Retina and Brain

  2020influential citation
• Coenzyme Q10 supplementation reverses diabetes-related impairments in long-term potentiation induction in hippocampal dentate gyrus granular cells: an in vivo study.

  2020cites this paper
• Antioxidants and Nanotechnology: Promises and Limits of Potentially Disruptive Approaches in the Treatment of Central Nervous System Diseases

  2019cites this paper
• Effect of coenzyme Q10 supplementation on diabetes induced memory deficits in rats

  2019cites this paper
• Effect of Nicotinamide Against Candida albicans

  2019cites this paper
• PGC-1α, Sirtuins and PARPs in Huntington’s Disease and Other Neurodegenerative Conditions: NAD+ to Rule Them All

  2019cites this paper
• The Influence of Nicotinamide on Health and Disease in the Central Nervous System

  2018cites this paper
• A high-throughput screen of real-time ATP levels in individual cells reveals mechanisms of energy failure

  2018cites this paper
• A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease

  2017cites this paper
• Potential of redox therapies in neurodegenerative disorders.

  2017cites this paper
• Amelioratory effect of coenzyme Q10 on potential human carcinogen Microcystin-LR induced toxicity in mice.

  2017cites this paper
• Deanna Protocol Program for ALS: Substantiation and Putative Mechanisms

  2016cites this paper
• Is Coenzyme Q10 Effective in Protection against Ulcerative Colitis? An Experimental Study in Rats.

  2016cites this paper
• Neuroprotective Effects of Thymoquinone on the Hippocampus in a Rat Model of Traumatic Brain Injury.

  2016cites this paper
• Nutraceuticals against Neurodegeneration: A Mechanistic Insight

  2016cites this paper
• Association of the COQ2 V393A Variant with Parkinson's Disease: A Case-Control Study and Meta-Analysis

  2015cites this paper
• Neuroprotection of Coenzyme Q10 in Neurodegenerative Diseases.

  2015cites this paper
• Attenuating effects of coenzyme Q10 and amlodipine in ulcerative colitis model in rats

  2015cites this paper
• SCHIZOPHRENIA: A FUNCTIONAL MEDICINE APPROACH TO TREATMENT

  2014cites this paper
• Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: an exploratory, open-label, dose-escalation study.

  2014cites this paper
• Elucidation of molecular mechanism involved in neuroprotective effect of Coenzyme Q10 in alcohol‐induced neuropathic pain

  2013cites this paper
• Generation and Characterization of BACHD Rats expressing full-length human mutant Huntingtin

  2013cites this paper
• Heterochromatinization induced by GAA-repeat hyperexpansion in Friedreich's ataxia can be reduced upon HDAC inhibition by vitamin B3.

  2013cites this paper
• Existing and emerging mitochondrial-targeting therapies for altering Parkinson's disease severity and progression.

  2013cites this paper
• Coenzyme Q10 supplementation reverses age-related impairments in spatial learning and lowers protein oxidation

  2013cites this paper
• Diabetic neuropathic pain development in type 2 diabetic mouse model and the prophylactic and therapeutic effects of coenzyme Q10.

  2013cites this paper
• A Study on the Lipid Lowering Effect of Coenzyme Q 10 in Dyslipidaemic Patients who Underwent Percutaneous Transluminal Coronary Angioplasty and receive Atorvastatin Therapy

  2013cites this paper
• Antioxidants in Huntington's disease.

  2012cites this paper
• Gastroprotective Efficacy of Coenzyme Q10 in Indomethacin-Induced Gastropathy: Other Potential Mechanisms

  2012cites this paper
• The Effects of Topical Coenzyme Q10 and Vitamin E d-α-Tocopheryl Polyethylene Glycol 1000 Succinate after Cataract Surgery: A Clinical and in vivo Confocal Study

  2012cites this paper
• Experimental models of HD and reflection on therapeutic strategies.

  2011cites this paper
• Huntington’s Disease: Clinical Experimental Therapeutics

  2011cites this paper
• Pharmacological Therapy in Parkinson's Disease: Focus on Neuroprotection

  2011cites this paper
• Chapter 14 – Huntington disease

  2011cites this paper
• 3-Nitropropionic Acid and Other Metabolic Toxin Lesions of the Striatum

  2011cites this paper
• Animal Models of Dementia

  2011cites this paper
• Validation of Dementia Models Employing Neuroimaging Techniques

  2011cites this paper
• Effect of lead toxicity on coenzyme Q levels in rat tissues.

  2010cites this paper
• Huntington disease

  2010cites this paper
• Protective Effect of L-Carnitine and Coenzyme Q10 on CCl4-Induced Liver Injury in Rats

  2010cites this paper
• The Effects of Exogenous Ubiquinone on Mitochondrial Function, Oxidative Damage, and Lifespan in Caenorhabditis elegans

  2010influential citation
• Coenzyme Q 10 and its effects in the treatment of neurodegenerative diseases

  2010cites this paper
• Coenzyme Q 10 : a progress towards the treatment of neurodegenerative disease

  2010cites this paper
• Parkinson's disease: mitochondrial molecular pathology, inflammation, statins, and therapeutic neuroprotective nutrition.

  2010cites this paper
• Coenzyme Q10: a novel gastroprotective effect via modulation of vascular permeability, prostaglandin E₂, nitric oxide and redox status in indomethacin-induced gastric ulcer model.

  2010cites this paper
• Mitochondrial matters of the brain: the role in Huntington’s disease

  2010cites this paper
• The molecular pathogenesis of Huntington’s disease

  2009cites this paper
• Neuroprotective and neurorestorative strategies for neuronal injury

  2009cites this paper
• The Neuroprotective Role of Micronutrients in Parkinson’s Disease

  2009cites this paper
• Neuroprotective effects of compounds with antioxidant and anti-inflammatory properties in a Drosophila model of Parkinson's disease

  2009cites this paper
• Mitochondria as targets for chemotherapy

  2009cites this paper
• The failure of mitochondria leads to neurodegeneration: Do mitochondria need a jump start?

  2009cites this paper
• Combination therapy with Coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson’s and Huntington’s Diseases

  2009cites this paper
• Strategies of neuroprotection in an in vivo model of retinal degeneration induced by mitochondrial dysfunction

  2009influential citation
• Restoration and putative protection in parkinsonism

  2009cites this paper
• Coenzyme Q10 effects in neurodegenerative disease

  2009cites this paper
• Coenzyme Q10 and its effects in the treatment of neurodegenerative diseases

  2009cites this paper
• Nutritional deficiencies, metabolic disorders and toxins affecting the nervous system

  2008cites this paper
• Statin Adverse Effects

  2008cites this paper
• Evidence of Oxidant Damage in Huntington's Disease: Translational Strategies Using Antioxidants

  2008cites this paper
• Role of β-Hydroxy-γ-Trimethylammonium Butyrate (L-carnitine) and Ubiquinone (CoQ10) in Combating the Deteriorative Effect of Halogenated Alkanes in Liver

  2008cites this paper
• Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism

  2008cites this paper
• Mitochondrial Approaches for Neuroprotection

  2008cites this paper
• Coenzyme Q treatment of neurodegenerative diseases of aging.

  2007cites this paper
• Application of MRS to mouse models of neurodegenerative illness

  2007cites this paper
• Reactive Oxygen Species and p38 Mitogen-Activated Protein Kinase Activate Bax to Induce Mitochondrial Cytochrome c Release and Apoptosis in Response to Malonate

  2007cites this paper
• Deneysel spinal kord yaralanmas›nda koenzim Q 10 'un etkinlii EfficiencyofcoenzymeQ 10 at experimental spinal cord injury

  2007cites this paper
• Huntington's disease: progress and potential in the field

  2007cites this paper
• [Efficiency of coenzyme Q(10) at experimental spinal cord injury].

  2007cites this paper
• Restoration of cellular energetic balance with L-carnitine in the neuro-bioenergetic approach for cancer prevention and treatment.

  2007cites this paper
• Huntington ’ s disease : progress and potential in the fi eld

  2007cites this paper
• Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease.

  2006cites this paper
• REACTIVE OXYGEN SPECIES AND P 38 MAPK ACTIVATE BAX TO INDUCE MITOCHONDRIAL CYTOCHROME C RELEASE AND APOPTOSIS IN RESPONSE TO MALONATE

  2006cites this paper
• Oxidative stress and the viability of osteoblasts and cerebellar granule neurones.

  2006cites this paper
• CHAPTER 33 – Polyalanine and Polyglutamine Diseases: Possible Common Mechanisms?

  2006cites this paper
• Coenzyme Q10 modulates cognitive impairment against intracerebroventricular injection of streptozotocin in rats.

  2006cites this paper
• An investigation into the neuroprotective properties of acyclovir

  2006cites this paper
• Delayed treatment with nicotinamide inhibits brain energy depletion, improves cerebral microperfusion, reduces brain infarct volume, but does not alter neurobehavioral outcome following permanent focal cerebral ischemia in Sprague Dawley rats.

  2006cites this paper
• Effects of 3-nitropropionic acid on the cortical and peripheral nervous activity in rats

  2005cites this paper
• MPTP-induced deficits in motor activity: Neuroprotective effects of the spintrapping agent, α-phenyl-tert-butyl-nitrone (PBN)

  2005cites this paper
• Emerging chemotherapeutic strategies for Huntington’s disease

  2005cites this paper
• Huntington’s Disease

  2005cites this paper
• Clinical trials of coenzyme Q10 in neurological disorders

  2005cites this paper
• Nicotinamide Modulates Energy Utilization and Improves Functional Recovery from Ischemia in the In Vitro Rabbit Retina

  2005cites this paper
• Evidence for a role of energy dysregulation in the MDMA-induced depletion of brain 5-HT.

  2005cites this paper
• Neurodegenerative Diseases: Magnetic resonance spectroscopy of neurodegenerative illness

  2005cites this paper
• Mitochondrial Dysfunction and Oxidative Damage in Alzheimer's and Parkinson's Diseases and Coenzyme Q10 as a Potential Treatment

  2004cites this paper
• The Energetics of Huntington's Disease

  2004cites this paper
• Protective Effect of Nicotinamide on Neuronal Cells under Oxygen and Glucose Deprivation and Hypoxia/Reoxygenation

  2004cites this paper
• Experimental therapeutics in transgenic mouse models of Huntington's disease

  2004cites this paper